Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective

BACKGROUND: Effect of neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC) has remained under investigation. We investigated its effect from a unique perspective and discussed its application. PATIENTS AND METHODS: We retrospecively analyzed consecutive 131 PDAC patients who un...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurata, Yoshihiro, Shiraki, Takayuki, Ichinose, Masanori, Kubota, Keiichi, Imai, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986386/
https://www.ncbi.nlm.nih.gov/pubmed/33752677
http://dx.doi.org/10.1186/s12957-021-02192-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986386/
https://www.ncbi.nlm.nih.gov/pubmed/33752677
http://dx.doi.org/10.1186/s12957-021-02192-8

Ejemplares similares